Dermata Therapeutics Valuation
| DRMAW Stock | USD 0.01 0.00 0.00% |
Dermata Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Dermata Therapeutics from reviewing the firm fundamentals such as Number Of Shares Shorted of 1.2 K, total debt of 1.62 M, and Net Income of (7.79 M) as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Dermata Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Dermata Therapeutics is based on 3 months time horizon. Increasing Dermata Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Dermata stock is determined by what a typical buyer is willing to pay for full or partial control of Dermata Therapeutics Warrant. Since Dermata Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dermata Stock. However, Dermata Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0088 | Real 0.007128 | Hype 0.01 | Naive 0.007983 |
The intrinsic value of Dermata Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dermata Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Dermata Therapeutics Warrant helps investors to forecast how Dermata stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dermata Therapeutics more accurately as focusing exclusively on Dermata Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Dermata Therapeutics' intrinsic value based on its ongoing forecasts of Dermata Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Dermata Therapeutics' closest peers.
Dermata Therapeutics Cash |
|
Dermata Valuation Trend
Analysing the historical paterns of Dermata Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Dermata Therapeutics Warrant over time and is usually enough for investors to make rational market timing decisions.
Dermata Therapeutics Total Value Analysis
Dermata Therapeutics Warrant is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of 1.62 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dermata Therapeutics fundamentals before making investing decisions based on enterprise value of the companyDermata Therapeutics Asset Utilization
One of the ways to look at asset utilization of Dermata is to check how much profit was generated for every dollar of assets it reports. Dermata Therapeutics Warrant shows a negative utilization of assets of -0.91 percent, losing $0.009068 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Dermata Therapeutics Warrant shows how discouraging it operates for each dollar spent on its assets.Dermata Therapeutics Profitability Analysis
Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0.About Dermata Therapeutics Valuation
Our relative valuation model uses a comparative analysis of Dermata Therapeutics. We calculate exposure to Dermata Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dermata Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | (370.30) | (388.81) |
Dermata Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Dermata Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 195 K |
Dermata Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Dermata Therapeutics Warrant and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Dermata we look at many different elements of the entity such as Dermata's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Dermata Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Dermata Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Dermata Therapeutics' worth.Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.